Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Gossamer Bio, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 98 | 109 | +11 |
| Shares | 209.2M | 197.8M | −11.4M (−5.5%) |
| Value | $192.0M | $233.5M | +$41.5M (+21.6%) |
New holders (26)
Institutions that held Gossamer Bio, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (15)
Institutions that held Gossamer Bio, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Armistice Capital, LLC | 4,156,000 | $3.79M |
| Alyeska Investment Group, L.P. | 2,913,216 | $2.66M |
| Weiss Asset Management LP | 2,000,000 | $1.82M |
| Tang Capital Management LLC | 838,600 | $765.2K |
| Man Group plc | 379,882 | $346.6K |
| Boothbay Fund Management, LLC | 58,335 | $53.2K |
| XTX Topco Ltd | 53,458 | $48.8K |
| Ameriprise Financial Inc | 39,161 | $35.7K |
| Two Sigma Securities, LLC | 31,683 | $28.9K |
| HCR Wealth Advisors | 22,000 | $20.1K |
| Public Employees Retirement System of Ohio | 20,700 | $18.9K |
| waypoint wealth counsel | 11,758 | $10.7K |
| Arcus Capital Partners, LLC | 10,042 | $9.16K |
| Simplex Trading, LLC | 10,505 | $9.00K |
| Advisory Services Network, LLC | 40 | $37 |